SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers
about
SMARCA4-deficient pulmonary adenocarcinoma: clinicopathological, immunohistochemical, and molecular characteristics of a novel aggressive neoplasm with a consistent TTF1(neg)/CK7(pos)/HepPar-1(pos) immunophenotype.Targeting AURKA-CDC25C axis to induce synthetic lethality in ARID1A-deficient colorectal cancer cells
P2860
SMARCA4-inactivating mutations increase sensitivity to Aurora kinase A inhibitor VX-680 in non-small cell lung cancers
description
2017 nî lūn-bûn
@nan
2017 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2017 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2017年の論文
@ja
2017年論文
@yue
2017年論文
@zh-hant
2017年論文
@zh-hk
2017年論文
@zh-mo
2017年論文
@zh-tw
2017年论文
@wuu
name
SMARCA4-inactivating mutations ...... in non-small cell lung cancers
@ast
SMARCA4-inactivating mutations ...... in non-small cell lung cancers
@en
type
label
SMARCA4-inactivating mutations ...... in non-small cell lung cancers
@ast
SMARCA4-inactivating mutations ...... in non-small cell lung cancers
@en
prefLabel
SMARCA4-inactivating mutations ...... in non-small cell lung cancers
@ast
SMARCA4-inactivating mutations ...... in non-small cell lung cancers
@en
P2093
P2860
P356
P1476
SMARCA4-inactivating mutations ...... in non-small cell lung cancers
@en
P2093
Adi F Gazdar
Bruce A Posner
David A Wheeler
John D Minna
Luc Girard
Michael A White
Michael Peyton
Shuguang Wei
TaeHyun Hwang
Vural Tagal
P2860
P2888
P356
10.1038/NCOMMS14098
P407
P577
2017-01-19T00:00:00Z
P6179
1046605356